PESV also inhibited cultured human leukemia (K562) cell growth and murine hepatoma (H22) tumor development in vivo (14 days treatment), decreased PI3K and AKT protein levels, and induced apoptosis [23, 24]. Here, AKT1 is linked to neoplasm.